Saint Luke's Mid America Heart Institute; University of Missouri-Kansas City, Kansas City, MO.
Saint Luke's Mid America Heart Institute.
Eur Heart J Qual Care Clin Outcomes. 2016;2(3):208-214. doi: 10.1093/ehjqcco/qcw016. Epub 2016 Mar 25.
Almost a third of outpatients with chronic coronary artery disease (CAD) report having angina in the prior month, which is frequently under-recognized by their cardiologists. Whether under-recognition is associated with less treatment escalation to control angina, and potential underuse of treatment, is unknown.
Patients with CAD from 25 US cardiology outpatient practices completed the Seattle Angina Questionnaire (SAQ) prior to their clinic visit, and angina was categorized as daily, weekly, monthly and no angina. Cardiologists (n=155) independently quantified patients' angina, blinded to patients' SAQ scores. Under-recognition was defined as the physician reporting a lower category of angina frequency than the patient. Among 1257 patients with CAD, 411 reported angina in the past month, of whom 178 (43.3%) patients were under-recognized. Treatment escalation-defined as intensification (up-titration or addition) of antianginal medications, referral for diagnostic testing or revascularization, or hospital admission-occurred in 106 (25.8%) patients with angina. Patients with under-recognized angina were less likely to get treatment escalation than patients whose angina was appropriately recognized (8.4% vs 39.1%, P<0.001). In a hierarchical multivariable logistic regression model adjusting for demographic and clinical characteristics, as well as the burden of angina, under-recognition remained strongly associated with a lack of treatment escalation (adjusted OR 0.10, 95% CI 0.04-0.21, P<0.001).
Under-recognition of angina in cardiology outpatient practices is associated with less aggressive treatment escalation and may lead to poorer angina control. Standardizing clinical recognition of angina using validated tools could reduce under-recognition of angina, facilitate treatment, and potentially improve outcomes.
近三分之一的慢性冠状动脉疾病(CAD)门诊患者报告在上个月有胸痛,而他们的心脏病专家经常对此认识不足。尚不清楚这种认识不足是否与控制胸痛的治疗升级较少以及潜在的治疗不足有关。
来自 25 家美国心脏病学门诊实践的 CAD 患者在就诊前完成了西雅图心绞痛问卷(SAQ),并将心绞痛分为每日、每周、每月和无心绞痛。心脏病专家(n=155)独立评估患者的心绞痛,对患者的 SAQ 评分不知情。低估定义为医生报告的心绞痛频率类别低于患者。在 1257 例 CAD 患者中,411 例报告过去一个月有胸痛,其中 178 例(43.3%)患者被低估。治疗升级定义为抗心绞痛药物的强化(滴定或加量)、诊断性检查或血运重建的转诊,或住院,在 106 例有胸痛的患者中发生。与心绞痛被正确识别的患者相比,被低估的心绞痛患者更不可能接受治疗升级(8.4%比 39.1%,P<0.001)。在调整人口统计学和临床特征以及心绞痛负担的分层多变量逻辑回归模型中,低估与缺乏治疗升级仍然密切相关(调整后的 OR 0.10,95%CI 0.04-0.21,P<0.001)。
在心脏病学门诊实践中,对心绞痛的低估与治疗升级不积极有关,可能导致心绞痛控制不佳。使用经过验证的工具标准化对心绞痛的临床识别可以减少对心绞痛的低估,促进治疗,并可能改善结局。